CME Group (CME)
(Real Time Quote from BATS)
$215.23 USD
+2.07 (0.97%)
Updated Sep 23, 2024 01:42 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Income Statements
Fiscal Year end for CME Group Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 5,579 | 5,019 | 4,690 | 4,884 | 4,868 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 5,579 | 5,019 | 4,690 | 4,884 | 4,868 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,143 | 2,004 | 2,045 | 2,246 | 2,280 |
Income After Depreciation & Amortization | 3,436 | 3,016 | 2,645 | 2,637 | 2,588 |
Non-Operating Income | 877 | 637 | 895 | 251 | 280 |
Interest Expense | 159 | 163 | 167 | 166 | 178 |
Pretax Income | 4,154 | 3,490 | 3,374 | 2,722 | 2,690 |
Income Taxes | 927 | 799 | 737 | 616 | 574 |
Minority Interest | 0 | 0 | 1 | 1 | -1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 3,226 | 2,691 | 2,637 | 2,106 | 2,116 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 3,226 | 2,691 | 2,636 | 2,105 | 2,117 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 3,788 | 3,379 | 3,031 | 3,102 | 3,061 |
Depreciation & Amortization (Cash Flow) | 353 | 363 | 385 | 464 | 473 |
Income After Depreciation & Amortization | 3,436 | 3,016 | 2,645 | 2,637 | 2,588 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 359.50 | 359.18 | 358.93 | 358.52 | 358.24 |
Diluted EPS Before Non-Recurring Items | 9.34 | 7.97 | 6.67 | 6.72 | 6.80 |
Diluted Net EPS (GAAP) | 8.86 | 7.40 | 7.29 | 5.87 | 5.91 |
Fiscal Year end for CME Group Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 1,532.50 | 1,487.90 | 1,439.30 | 1,337.80 | 1,360.20 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 1,532.50 | 1,487.90 | 1,439.30 | 1,337.80 | 1,360.20 |
SG&A, R&D, and Dept/Amort Expenses | 531.90 | 528.30 | 576.10 | 517.60 | 521.60 |
Income After SG&A, R&D, and Dept/Amort Expenses | 1,000.60 | 959.60 | 863.20 | 820.20 | 838.60 |
Non-Operating Income | 194.00 | 193.70 | 182.50 | 193.70 | 218.00 |
Interest Expense | 40.10 | 39.90 | 39.70 | 39.60 | 40.20 |
Pretax Income | 1,154.50 | 1,113.40 | 1,006.00 | 974.30 | 1,016.40 |
Income Taxes | 271.30 | 258.20 | 191.40 | 224.10 | 238.80 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 883.20 | 855.20 | 814.60 | 750.20 | 777.60 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 883.20 | 855.20 | 814.60 | 750.20 | 777.60 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 359.87 | 359.83 | 359.69 | 359.62 | 359.43 |
Diluted EPS Before Non-Recurring Items | 2.56 | 2.50 | 2.37 | 2.25 | 2.30 |
Diluted Net EPS (GAAP) | 2.42 | 2.35 | 2.23 | 2.06 | 2.14 |